Induced pluripotent stem cell technology has also made it possible to conduct parallel high-throughput compound screens on defined cell types derived from a large number of different individuals. This technology will allow the screening process to account for genetic differences in the response to potential new drugs. As induced pluripotent stem cells can now be easily generated from patients, including those with inherited diseases and their unaffected relatives, they also provide a new way to investigate the molecular basis of disease-prone cells side-by-side in the lab, enabling the development of improved pharmaceutical interventions.
No comments:
Post a Comment